Variant report
Variant | esv3427858 |
---|---|
Chromosome Location | chr1:102071506-102072102 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529442858 | chr1:102071538-102071539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs12068329 | chr1:102071565-102071566 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs117982752 | chr1:102071591-102071592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs74494798 | chr1:102071634-102071635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs11164245 | chr1:102071635-102071636 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs570416012 | chr1:102071651-102071652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537587417 | chr1:102071696-102071697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs556173611 | chr1:102071715-102071716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs373802992 | chr1:102071716-102071717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs375914377 | chr1:102071725-102071726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs143271338 | chr1:102071734-102071735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11164246 | chr1:102071779-102071780 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs553671494 | chr1:102071815-102071816 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572035390 | chr1:102071839-102071840 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570455481 | chr1:102071862-102071863 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs11164247 | chr1:102071863-102071864 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs556407762 | chr1:102071908-102071909 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs557771789 | chr1:102071938-102071939 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs576382042 | chr1:102071993-102071994 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543555710 | chr1:102071999-102072000 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs111889196 | chr1:102072037-102072038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs377554607 | chr1:102072049-102072050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs147417576 | chr1:102072085-102072086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs547143400 | chr1:102072095-102072096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12074808 | chr1:102072102-102072103 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 22429812 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:102070800-102072200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr1:102070800-102072600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr1:102071000-102072800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr1:102071000-102072800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr1:102071200-102071600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr1:102071400-102071800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr1:102071800-102072000 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr1:102072000-102072400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |